doxorubicin hydrochloride has been researched along with Leukemia P388 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acton, EM; Mosher, CW; Tong, GL; Wolgemuth, RL | 1 |
Acton, EM; Tong, GL | 1 |
Barrero, AF; Cabrera, E; Chahboun, R; Cortés, M; Lara, M; Manzaneda, EA; Rivas, AR | 1 |
3 other study(ies) available for doxorubicin hydrochloride and Leukemia P388
Article | Year |
---|---|
Intensely potent morpholinyl anthracyclines.
Topics: Animals; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation, Preclinical; Indicators and Reagents; Leukemia L1210; Leukemia P388; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Structure-Activity Relationship | 1984 |
Synthesis and preliminary antitumor evaluation of 5-iminodoxorubicin.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Leukemia P388; Mice | 1981 |
Synthesis of 11,12-epoxydrim-8,12-en-11-ol, 11,12-diacetoxydrimane, and warburganal from (-)-sclareol.
Topics: Animals; Antineoplastic Agents; Benzofurans; Diterpenes; Drug Screening Assays, Antitumor; Humans; Leukemia P388; Naphthalenes; Porifera; Sesquiterpenes; Structure-Activity Relationship; Tumor Cells, Cultured | 1999 |